Results 191 to 200 of about 60,638 (316)

Use of adjunctive glycaemic agents with vascular protective properties in individuals with type 1 diabetes: Potential benefits and risks

open access: yesDiabetes, Obesity and Metabolism, Volume 27, Issue 6, Page 2920-2939, June 2025.
Abstract Glycaemic therapy in type 1 diabetes (T1D) is focused on insulin, with the majority of studies investigating different insulin preparations, delivery devices and dosing accuracy methods. While insulin deficiency is the key mechanism for hyperglycaemia in T1D, individuals with this condition can also develop insulin resistance (IR), making ...
Ahmad M. Rajab   +2 more
wiley   +1 more source

Starvation ketoacidosis [PDF]

open access: yesJournal of the Intensive Care Society, 2016
Charlotte J, Frise, Lucy, Mackillop
openaire   +2 more sources

Safety and clinical effectiveness of iGlarLixi in people with type 2 diabetes mellitus in Mexico

open access: yesDiabetes, Obesity and Metabolism, Volume 27, Issue 6, Page 3389-3396, June 2025.
Abstract Aims To evaluate the safety and effectiveness of iGlarLixi in people with type 2 diabetes mellitus (T2DM) in clinical practice in Mexico. Materials and Methods This was a prospective, observational, multicentre study in adults with T2DM who were prescribed iGlarLixi in routine clinical practice in Mexico. The participants were followed for 24 ±
Juan Rosas‐Guzman   +4 more
wiley   +1 more source

Epidemiological characteristics of ketoacidosis among Korean diabetic patients

open access: bronze, 1987
H K Lee   +9 more
openalex   +1 more source

Home - About - Disclaimer - Privacy